Today: 9 June 2026
Lam Research stock jumps as new CEA-Leti R&D pact lands during choppy U.S. session
2 February 2026
1 min read

Lam Research stock jumps as new CEA-Leti R&D pact lands during choppy U.S. session

New York, Feb 2, 2026, 11:00 EST — Regular session

Lam Research shares rose 3.1% to $240.70 in morning trading on Monday, after the chipmaking equipment maker announced it had expanded a research collaboration with CEA-Leti. The stock hit as high as $242.81 earlier in the session.

The move came in a jittery session on CME Group’s decision to lift margin requirements for precious metals and ahead of a crowded week of earnings and U.S. economic data. “You’re seeing investors being more selective,” said Jim Baird of Plante Moran Financial Advisors. Reuters

Lam’s shares have been trading off last week’s quarterly report, when the company forecast third-quarter revenue of $5.7 billion, plus or minus $300 million, above Wall Street estimates. It also projected adjusted earnings of $1.35 a share, plus or minus 10 cents, after posting adjusted profit of $1.27 a share on revenue of $5.34 billion in the second quarter. Tim Archer said the market is shifting to “smaller, more complex three-dimensional devices and packages.” Reuters

In Monday’s statement, Lam said the multi-year agreement with CEA-Leti will focus on new materials and fabrication processes for so-called specialty devices, including micro-electromechanical systems (MEMS), sensors, power-management and radio-frequency parts, and photonics. Vahid Vahedi called the opportunities “immense,” while Sébastian Dauvé said the work should speed the move from process ideas to “validated functionality.” PR Newswire

Lam outpaced some chip-tool peers. Applied Materials rose 1.6% and ASML Holding gained about 1%, while KLA Corp. slipped nearly 0.9%.

Lam is a major supplier of wafer-fab equipment — the machines that etch and coat silicon wafers during chipmaking — and its order trends are watched as a read on chipmakers’ spending plans. Industry group SEMI has forecast global wafer-fab equipment sales will rise about 9% to $126 billion in 2026, Reuters reported in December.

But the stock’s next leg is not just about R&D headlines. Demand for chip gear can swing fast if customers trim capital spending, and the group remains exposed to policy shifts that can limit sales of advanced tools to certain markets.

The next catalysts land this week: the U.S. Bureau of Labor Statistics is due to publish the JOLTS job openings report on Tuesday and the January employment report on Friday, Feb. 6, while investors also digest a heavy run of big-ticket earnings.

Stock Market Today

  • Semiconductor Stock Poised to Surpass Micron Technology by 2028
    June 9, 2026, 10:18 AM EDT. Micron Technology has surged nearly 800% recently, driven by high demand and pricing power in memory chips, pushing its market cap past $1 trillion. However, analysts predict supply constraints easing by 2028 could cause earnings to peak and decline, potentially halving share value to around $517.50. Meanwhile, a major semiconductor competitor valued around $650 billion is expanding production, potentially surpassing Micron's value by 2028. The industry faces cyclical dynamics as new manufacturing capacity comes online globally, impacting pricing and earnings. Investors are watching these shifts closely for long-term positioning amid evolving chip supply and demand.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Apple stock price today: AAPL ticks up on India tax win, analyst call — what investors watch next
Previous Story

Apple stock price today: AAPL ticks up on India tax win, analyst call — what investors watch next

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next
Next Story

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next

Go toTop